GBP5 and familial avascular necrosis of femoral head: In osteonecrosis of the femoral head, GBP5 expression correlates with disease progression, severity, and treatment outcomes, making it a promising marker for predicting disease risk and as a therapeutic target, particularly in relation to gender-specific factors (72).